{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:16:39Z","timestamp":1788246999596,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Research Council of Hormozgan University of Medical Sciences, Bandar Abbas","award":["4010551"],"award-info":[{"award-number":["4010551"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-026-01970-1","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:52:33Z","timestamp":1788245553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuroprotective and cognitive-enhancing effects of \u03b3-Oryzanol in bile duct ligation\u2013induced hepatic encephalopathy in rats"],"prefix":"10.1007","volume":"41","author":[{"given":"Elias","family":"Kargar-Abargouei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaheh","family":"Zare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9449-4026","authenticated-orcid":false,"given":"Maryam Arab","family":"Firouzjaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4494-2262","authenticated-orcid":false,"given":"Esmaeel","family":"Ghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"1970_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10339-011-0430-z","volume":"13","author":"M Antunes","year":"2012","unstructured":"Antunes M, Biala G (2012) The novel object recognition memory: Neurobiology, test procedure, and its modifications. Cogn Process 13:93\u2013110","journal-title":"Cogn Process"},{"key":"1970_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1006\/abio.1996.0292","volume":"239","author":"IFF Benzie","year":"1996","unstructured":"Benzie IFF, Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: The FRAP assay. Anal Biochem 239:70\u201376","journal-title":"Anal Biochem"},{"key":"1970_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40265-018-1017-0","volume":"79","author":"RF Butterworth","year":"2019","unstructured":"Butterworth RF (2019) Hepatic encephalopathy in cirrhosis: Pathology and pathophysiology. Drugs 79:17\u201321","journal-title":"Drugs"},{"key":"1970_CR6","first-page":"1023","volume":"36","author":"L Chen","year":"2021","unstructured":"Chen L, Wang Y, Zhang X (2021) \u03b3-Oryzanol attenuates hepatic fibrosis via suppression of NF-\u03baB signaling in cholestatic rats. J Gastroenterol Hepatol 36:1023\u20131031","journal-title":"J Gastroenterol Hepatol"},{"key":"1970_CR9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"GL Ellman","year":"1959","unstructured":"Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70\u201377","journal-title":"Arch Biochem Biophys"},{"key":"1970_CR12","first-page":"125","volume":"41","author":"MS Garcia-Ayllon","year":"2005","unstructured":"Garcia-Ayllon MS, Cauli O, Felipo V (2005) Learning and memory deficits in rats with hepatic encephalopathy. Hepatology 41:125\u2013132","journal-title":"Hepatology"},{"key":"1970_CR13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/hepr.13842","volume":"53","author":"R Jover","year":"2023","unstructured":"Jover R, Rodrigo R, Felipo V (2023) Bile duct ligation in rats: A reliable model of hepatic encephalopathy. Hepatol Res 53:145\u2013158","journal-title":"Hepatol Res"},{"key":"1970_CR14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0168-8278(23)00749-3","volume":"78","author":"AJ Kerbert","year":"2023","unstructured":"Kerbert AJ, Jalan R (2023) Recent advances in understanding hepatic encephalopathy. J Hepatol 78:643\u2013657","journal-title":"J Hepatol"},{"key":"1970_CR15","first-page":"1845","volume":"45","author":"S Kim","year":"2020","unstructured":"Kim S, Lee H, Park J (2020) \u03b3-Oryzanol activates Nrf2-ARE pathway and protects against glutamate-induced excitotoxicity. Neurochem Res 45:1845\u20131854","journal-title":"Neurochem Res"},{"key":"1970_CR16","first-page":"45","volume":"32","author":"J Lee","year":"2023","unstructured":"Lee J, Choi Y, Kim D (2023) \u03b3-Oryzanol ameliorates hyperammonemia-induced synaptic dysfunction in cortical neurons. Exp Neurobiol 32:45\u201356","journal-title":"Exp Neurobiol"},{"key":"1970_CR17","first-page":"725","volume":"863","author":"G Mestino","year":"2019","unstructured":"Mestino G, Biasi F (2019) Blood-brain barrier permeability of \u03b3-oryzanol and its neuroprotective effects. Eur J Pharmacol 863:725\u2013732","journal-title":"Eur J Pharmacol"},{"key":"1970_CR18","first-page":"120","volume":"148","author":"F Mohammadian","year":"2019","unstructured":"Mohammadian F, Arab Firouzjaei M, Haghani M et al (2019) Inhibition of inflammation is not enough for recovery of cognitive impairment in hepatic encephalopathy: Effects of minocycline and ibuprofen. Brain Res Bull 148:120\u2013132","journal-title":"Brain Res Bull"},{"key":"1970_CR21","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351\u2013358","journal-title":"Anal Biochem"},{"key":"1970_CR22","first-page":"5321","volume":"26","author":"S Patel","year":"2020","unstructured":"Patel S, Singh R (2020) Hepatoprotective effects of \u03b3-oryzanol in cholestatic liver injury. World J Gastroenterol 26:5321\u20135333","journal-title":"World J Gastroenterol"},{"key":"1970_CR23","first-page":"1499","volume":"41","author":"L Ridola","year":"2021","unstructured":"Ridola L, Riggio O (2021) Cognitive impairment in hepatic encephalopathy: Current concepts and therapeutic approaches. Liver Int 41:1499\u20131508","journal-title":"Liver Int"},{"key":"1970_CR25","first-page":"871","volume":"35","author":"CF Rose","year":"2020","unstructured":"Rose CF, Amodio P (2020) Hepatic encephalopathy: Current challenges and future prospects. Metab Brain Dis 35:871\u2013880","journal-title":"Metab Brain Dis"},{"key":"1970_CR27","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/hep.27210","volume":"60","author":"H Vilstrup","year":"2014","unstructured":"Vilstrup H, Amodio P, Bajaj J et al (2014) Hepatic encephalopathy in subchronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology 60:715\u2013735","journal-title":"Hepatology"},{"key":"1970_CR28","first-page":"4850","volume":"35","author":"X Wang","year":"2021","unstructured":"Wang X, Liu Z (2021) Antioxidant and anti-inflammatory properties of \u03b3-oryzanol: A comprehensive review. Phytother Res 35:4850\u20134864","journal-title":"Phytother Res"},{"key":"1970_CR32","first-page":"1892","volume":"59","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Li Q, Wang J (2022) \u03b3-Oryzanol inhibits CaMKII-ASK1-JNK signaling cascade in glutamate-induced excitotoxicity. Mol Neurobiol 59:1892\u20131903","journal-title":"Mol Neurobiol"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01970-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-026-01970-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01970-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:52:36Z","timestamp":1788245556000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-026-01970-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1970"],"URL":"https:\/\/doi.org\/10.1007\/s11011-026-01970-1","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"199"}}